MedPath

Healthy Eating and Active Lifestyle (HEAL): Breast Cancer Program Outcomes

Recruiting
Conditions
Breast Cancer
Registration Number
NCT06078761
Lead Sponsor
AdventHealth
Brief Summary

The goal of this single-group prospective study is to examine the impact of the Healthy Eating and Active Lifestyle (HEAL) Breast Cancer program on participants' perceived stress, biometrics, basic labs, lifestyle behaviors, self-efficacy, mental health, and quality of life.

Participants will participate in an 8-week program of 90-minute virtual sessions each week to decrease risk of cancer recurrence. Program participants can choose to participate in the research study which will include data collection (surveys, biometrics, basic labs). The data collection will occur at four timepoints - baseline prior to program start, post-program, 3 month follow-up, and 6 month follow-up.

Detailed Description

The study will include 45 subjects recruited from AdventHealth Medical Group in the HEAL Breast Cancer Program that consent to participate in the research study. The research study will include data collection along with the program participation. Patients who decline participation in the research study are able to participate in the HEAL Breast Cancer Program. The program sessions will be conducted virtually via Zoom by Dr. Amber Orman, a breast cancer physician board certified in radiation oncology and lifestyle medicine. There are eight program sessions, one per week, each lasting 90-minutes. The survey package includes nine questionnaires and is expected to take 60 minutes to complete.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
45
Inclusion Criteria
  1. Adult ≥ 18 years old
  2. Diagnosis of breast cancer
  3. Enrolled in the HEAL: Breast Cancer Program
  4. Able to speak, read, and understand English fluently
  5. Willing and able to provide informed consent
  6. Willing and able to comply with all study procedures and requirements for the duration of the study
Exclusion Criteria
  1. Not willing or able to provide informed consent
  2. Not willing or able to comply with all study procedures and requirements for the duration of the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Perceived Stress ScaleBaseline, Week 8, 3-month follow up, 6-month follow up

PSS-10 is a ten item questionnaire covering the last month using 5 point Likert scale with 0 = Never, 1 = Almost never, 2 = Sometimes, 3 = Fairly often, 4 = Very often.

Secondary Outcome Measures
NameTimeMethod
mini-Eating Assessment Tool (mini-EAT)Baseline, Week 8, 3-month follow up, 6-month follow up

mini-EAT is a 9-item validated brief dietary screener where participants indicate how often they eat food groups with 9 response options: I do not eat it at all, Less than 1 serving per week, 1-2 servings per week, 3-4 servings per week, 5-6 servings per week, 1 serving per day, 2-3 servings per day, 4-5 servings per day, 6 or more servings per day

Comprehensive metabolic panelBaseline, Week 8, 3-month follow up, 6-month follow up

Standard of care Comprehensive metabolic panel

Hemoglobin A1CBaseline, Week 8, 3-month follow up, 6-month follow up

Standard of care Hemoglobin A1C

WeightBaseline, Week 8, 3-month follow up, 6-month follow up

Weight in kilograms

Godin-Shephard Leisure-Time Physical Activity QuestionnaireBaseline, Week 8, 3-month follow up, 6-month follow up

Godin-Shephard Leisure-Time Physical Activity Questionnaire includes 3 categories that participants indicate number of times in a week they participate

Generalized Anxiety Disorder - 2 item scaleBaseline, Week 8, 3-month follow up, 6-month follow up

The GAD-2 is a 2-item scale about the last 2 weeks with response categories: 0 = not at all, 1 = several days, 2 = more than half the days, 3 = nearly every day

Patient Health Questionnaire - 2 itemBaseline, Week 8, 3-month follow up, 6-month follow up

The PHQ-2 is a 2-item scale about the last 2 weeks with response categories: 0 = not at all, 1 = several days, 2 = more than half the days, 3 = nearly every day

Functional Assessment of Cancer Therapy - General - 7-item versionBaseline, Week 8, 3-month follow up, 6-month follow up

The FACT-G7 is a 7 item scale about the last 7 days with response categories: 0 = not at all, 1 = a little bit, 2 = somewhat, 3 = quite a bit, 4 = very much

General Self-Efficacy ScaleBaseline, Week 8, 3-month follow up, 6-month follow up

The GSE includes 10 items with response categories: 1 = not at all true, 2 = hardly true, 3 = moderately true and 4 = exactly true

Body Mass IndexBaseline, Week 8, 3-month follow up, 6-month follow up

Body Mass Index (BMI)

Blood pressureBaseline, Week 8, 3-month follow up, 6-month follow up

Blood pressure both systolic and diastolic

Lipid panelBaseline, Week 8, 3-month follow up, 6-month follow up

Standard of care Lipid panel

Trial Locations

Locations (1)

AdventHealth

🇺🇸

Orlando, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath